VP, Business Development and Licensing

In This Role, You Will Lead business development and licensing for Recursion’s portfolio of first-in-class and best-in-class molecules. Build enduring relationships with senior BD/licensing counterparts at pharma and biotech. Identify value-maximizing development/commercialization partners for existing clinical and preclinical assets. With search/evaluation and cross-functional leads, identify, prioritize, and diligence in-licensing and asset acquisition opportunities in oncology and I&I. Structure, negotiate, and execute licensing, acquisition, co-development/co-commercialization, and spin-out agreements. Consolidate industry feedback and advise internal teams on critical data-package deliverables. Represent Recursion’s platform and acquisition strategy to senior scientific and business leaders. The Experience You’ll Need BS/BA in life sciences (biology, chemistry, pharmacy, medical). Advanced degree (JD, MBA, PhD, PharmD) strongly preferred. 12–15+ years in biotechnology/pharmaceutical industry, focused on oncology and I&I. 7+ years direct business development and licensing experience (buy-side and sell-side). Strong network of senior relationships across biotech and large pharma. Deep knowledge of drug development from early discovery through commercialization. Track record leading complex, multi-stakeholder negotiations and closing high-value transactions. Ability to manage multiple complex projects independently. Exceptional cross-functional collaboration and communication skills. Demonstrated interest in AI-enabled drug discovery. Working Location & Compensation Office-based role in New York City; remote flexibility; travel every 4–6 weeks. Estimated annual base salary: $336,380–$404,140, plus annual bonus, equity, and comprehensive benefits package. #J-18808-Ljbffr Scorpion Therapeutics